Clinical Trial Update: BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies [Phase 4]

View source ↗

Summary

Long-term follow-up results from the BENEFIT program in multiple sclerosis have completed phase 4 assessments.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED